Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback